- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有556家主力机构披露2025-06-30报告期持股数据，持仓量总计1.68亿股，占流通A股41.96%
- 波段诊断：
-
技术面诊股
诊断结果：7.0技术面打败了73%的股票
技术面评分前10的股票
近期的平均成本为122.75元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为122.75元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"122.75","date":1760601156,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2025.10.17","stock":"-3.03","trade":"-1.55","ind":"-3.04"},{"date":"2025.10.16","stock":"-1.65","trade":"0.01","ind":"-0.25"},{"date":"2025.10.15","stock":"2.13","trade":"2.13","ind":"1.73"},{"date":"2025.10.14","stock":"-5.72","trade":"-1.02","ind":"-2.54"},{"date":"2025.10.13","stock":"-3.11","trade":"-1.02","ind":"-0.93"},{"date":"2025.10.10","stock":"5.45","trade":"-0.88","ind":"-2.70"},{"date":"2025.10.09","stock":"-0.58","trade":"-0.38","ind":"1.47"},{"date":"2025.09.30","stock":"0.85","trade":"0.69","ind":"0.35"},{"date":"2025.09.29","stock":"1.58","trade":"0.77","ind":"2.05"},{"date":"2025.09.26","stock":"3.53","trade":"-1.00","ind":"-1.76"},{"date":"2025.09.25","stock":"1.71","trade":"-0.53","ind":"0.67"},{"date":"2025.09.24","stock":"1.60","trade":"1.74","ind":"1.80"},{"date":"2025.09.23","stock":"-2.87","trade":"-2.59","ind":"-0.29"},{"date":"2025.09.22","stock":"-2.49","trade":"-0.03","ind":"0.67"},{"date":"2025.09.19","stock":"-3.91","trade":"-1.89","ind":"-0.04"},{"date":"2025.09.18","stock":"5.19","trade":"-0.43","ind":"-1.06"},{"date":"2025.09.17","stock":"0.02","trade":"-0.76","ind":"1.16"},{"date":"2025.09.16","stock":"-2.33","trade":"-0.13","ind":"0.45"},{"date":"2025.09.15","stock":"0.88","trade":"-0.30","ind":"0.63"},{"date":"2025.09.12","stock":"1.08","trade":"0.40","ind":"-0.43"},{"date":"2025.09.11","stock":"1.98","trade":"0.93","ind":"3.36"}]
长春高新,深证成指,生物制品指数
压力支撑
该股压力位为122.72元，支撑位为120.31元。
[{"text":"\u538b\u529b\u4f4d","value":"122.72","date":1760630400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"120.31","date":1760630400,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.4资金面打败了16%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月17日 20:30
| 机构今日流向(万元) | -1918.15 | 机构5日流向(万元) | -5298.96 |
| 机构10日流向(万元) | -8447.92 | 机构20日流向(万元) | -26043.82 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加1484.33万股，其中基金净减仓112家，主力净增仓158家，请投资者中长期谨慎为宜。
截止2025-06-30，共556家主力机构（基金553家，一般法人3家），持仓量总计16766.25万股，占流通A股41.96%
其中，基金持仓与2024-12-31相比：
增仓：63家 ，增持 265.40万股
减仓：175家 ，减持 786.86万股
新出现在主力名单中：281家 ，持有2487.73万股
从主力名单中消失：123家 ，原持有574.16万股
其中，基金持仓与2024-12-31相比：
增仓：63家 ，增持 265.40万股
减仓：175家 ，减持 786.86万股
新出现在主力名单中：281家 ，持有2487.73万股
从主力名单中消失：123家 ，原持有574.16万股
消息面诊股
诊断结果：5.9消息面打败了7%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 长春高新：公司与ALK合作产品为ALK自主开发的3
2025-10-17 - 长春高新：公司相关借款大部分为利率较低的政策性贷款
2025-10-17 - 长春高新：10月16日持仓该股ETF资金净流出16
2025-10-17 - 长春高新：10月16日获融资买入7879.52万元
2025-10-17 - 2025年中国生长激素行业十大潜力企业排行榜（附榜
2025-10-16 - 长春高新：10月15日获融资买入7210.05万元
2025-10-16 - 昔日超级大牛股，拟赴港上市！
2025-10-15 - 长春高新：10月14日持仓该股ETF资金净流出64
2025-10-15 - 长春高新：10月14日获融资买入2.06亿元
2025-10-15 - 长春高新：子公司三价流感病毒裂解疫苗（BK-01佐
2025-10-14
消息列表
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-30 |
| 一般消息 | 高管变动 | 个人工作原因 | 2025-08-14 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派26元(含税) | 2025-04-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-07 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.5行业面打败了78%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2025.10.17","price":"-3.04","value":"-1.55"},{"date":"2025.10.16","price":"-0.25","value":"0.01"},{"date":"2025.10.15","price":"1.73","value":"2.13"},{"date":"2025.10.14","price":"-2.54","value":"-1.02"},{"date":"2025.10.13","price":"-0.93","value":"-1.02"},{"date":"2025.10.10","price":"-2.70","value":"-0.88"},{"date":"2025.10.09","price":"1.47","value":"-0.38"},{"date":"2025.09.30","price":"0.35","value":"0.69"},{"date":"2025.09.29","price":"2.05","value":"0.77"},{"date":"2025.09.26","price":"-1.76","value":"-1.00"},{"date":"2025.09.25","price":"0.67","value":"-0.53"},{"date":"2025.09.24","price":"1.80","value":"1.74"},{"date":"2025.09.23","price":"-0.29","value":"-2.59"},{"date":"2025.09.22","price":"0.67","value":"-0.03"},{"date":"2025.09.19","price":"-0.04","value":"-1.89"},{"date":"2025.09.18","price":"-1.06","value":"-0.43"},{"date":"2025.09.17","price":"1.16","value":"-0.76"},{"date":"2025.09.16","price":"0.45","value":"-0.13"},{"date":"2025.09.15","price":"0.63","value":"-0.30"},{"date":"2025.09.12","price":"-0.43","value":"0.40"},{"date":"2025.09.11","price":"3.36","value":"0.93"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 三生国健 | 7.05% | 12.68% | 6.3分 |
| 2 | 通化东宝 | 4.27% | 2.92% | 6.5分 |
| 3 | 华兰疫苗 | 3.95% | 11.56% | 6.0分 |
| 4 | 诺唯赞 | -0.52% | 0.00% | 6.2分 |
| 5 | ST未名 | -1.03% | 0.53% | 4.7分 |
| 6 | 赛升药业 | -1.52% | 9.15% | 5.5分 |
| 8 | 长春高新 | -2.48% | -11.03% | 5.8分 |
| 10 | 华兰生物 | -3.37% | 0.31% | 6.0分 |
| 12 | 天坛生物 | -3.50% | -1.70% | 5.9分 |
| 14 | 优宁维 | -3.64% | -1.46% | 5.5分 |
| 16 | 万泽股份 | -4.01% | 1.41% | 6.4分 |
| 18 | *ST双成 | -4.55% | -4.79% | 5.3分 |
| 20 | 卫光生物 | -4.70% | -1.07% | 5.4分 |
| 22 | 我武生物 | -5.17% | 1.60% | 5.9分 |
| 24 | 近岸蛋白 | -5.83% | -4.99% | 4.8分 |
| 26 | 博晖创新 | -6.41% | -0.54% | 5.6分 |
| 28 | 甘李药业 | -6.78% | -6.19% | 5.2分 |
| 30 | 安科生物 | -7.16% | -3.29% | 5.6分 |
| 32 | 艾迪药业 | -8.10% | -1.38% | 5.3分 |
| 34 | - | -8.51% | 0.37% | 分 |
| 36 | 赛伦生物 | -8.72% | -2.30% | 5.6分 |
| 38 | 智飞生物 | -9.28% | -4.11% | 4.7分 |
| 40 | 诺诚健华 | -10.88% | -2.22% | 4.5分 |
| 42 | 迈威生物 | -11.00% | 0.78% | 4.8分 |
| 44 | 荣昌生物 | -11.61% | 5.42% | 5.3分 |
| 46 | - | -12.76% | -0.65% | 分 |
| 48 | 康希诺 | -14.24% | -4.72% | 5.1分 |
| 50 | 智翔金泰 | -14.98% | -3.36% | 4.6分 |
| 52 | 君实生物 | -18.71% | -2.04% | 5.0分 |
| 54 | *ST四环 | - | 5.70% | 5.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 12/73 ， 14/73。
[{"date":"2025-06-30","value":"4.29","vol":"-1.13"},{"date":"2025-03-31","value":"2.03","vol":"0.46"},{"date":"2024-12-31","value":"11.46","vol":"-1.01"},{"date":"2024-09-30","value":"12.38","vol":"1.37"},{"date":"2024-06-30","value":"7.82","vol":"0.48"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.29 | 2.03 | 11.46 | 12.38 | 7.82 |
| 行业(%) | -1.13 | 0.46 | -1.01 | 1.37 | 0.48 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"83.35","vol":"66.99"},{"date":"2025-03-31","value":"88.22","vol":"68.43"},{"date":"2024-12-31","value":"85.72","vol":"68.53"},{"date":"2024-09-30","value":"85.60","vol":"70.57"},{"date":"2024-06-30","value":"84.62","vol":"68.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
83.35 | 88.22 | 85.72 | 85.60 | 84.62 |
| 行业(%) | 66.99 | 68.43 | 68.53 | 70.57 | 68.37 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 32/73 ， 41/73。
[{"date":"2025-06-30","value":"-0.54","vol":"6771.82"},{"date":"2025-03-31","value":"-5.66","vol":"6125.27"},{"date":"2024-12-31","value":"-7.55","vol":"46.46"},{"date":"2024-09-30","value":"-2.75","vol":"178.44"},{"date":"2024-06-30","value":"7.63","vol":"19.00"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.54 | -5.66 | -7.55 | -2.75 | 7.63 |
| 行业(%) | 6771.82 | 6125.27 | 46.46 | 178.44 | 19.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-42.85","vol":"5.36"},{"date":"2025-03-31","value":"-44.95","vol":"-8.46"},{"date":"2024-12-31","value":"-43.01","vol":"-8.35"},{"date":"2024-09-30","value":"-22.80","vol":"-53.42"},{"date":"2024-06-30","value":"-20.40","vol":"-8.90"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-42.85 | -44.95 | -43.01 | -22.80 | -20.40 |
| 行业(%) | 5.36 | -8.46 | -8.35 | -53.42 | -8.90 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 10/73 ， 42/73。
[{"date":"2025-06-30","value":"0.21","vol":"0.13"},{"date":"2025-03-31","value":"0.10","vol":"0.06"},{"date":"2024-12-31","value":"0.44","vol":"0.28"},{"date":"2024-09-30","value":"0.34","vol":"0.22"},{"date":"2024-06-30","value":"0.22","vol":"0.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.21 | 0.10 | 0.44 | 0.34 | 0.22 |
| 行业(次) | 0.13 | 0.06 | 0.28 | 0.22 | 0.14 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.23","vol":"0.55"},{"date":"2025-03-31","value":"0.07","vol":"0.26"},{"date":"2024-12-31","value":"0.40","vol":"1.15"},{"date":"2024-09-30","value":"0.31","vol":"0.87"},{"date":"2024-06-30","value":"0.21","vol":"0.54"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.23 | 0.07 | 0.40 | 0.31 | 0.21 |
| 行业(次) | 0.55 | 0.26 | 1.15 | 0.87 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，居行业前列，两项指标的行业排名分别为 20/73 ， 44/73。
[{"date":"2025-06-30","value":"18.03","vol":"-1377.61"},{"date":"2025-03-31","value":"19.05","vol":"-46.99"},{"date":"2024-12-31","value":"0.27","vol":"-9.01"},{"date":"2024-09-30","value":"29.83","vol":"-29.47"},{"date":"2024-06-30","value":"24.32","vol":"-36179.91"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 18.03 | 19.05 | 0.27 | 29.83 | 24.32 |
| 行业 | -1377.61 | -46.99 | -9.01 | -29.47 | -36179.91 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.46","vol":"1.56"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.27","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"3.05","vol":"2.68"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 2.46 | - | 3.27 | - | 3.05 |
| 行业 | 1.56 | 0.00 | 2.00 | 0.00 | 2.68 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 27/73 ， 25/73。
[{"date":"2025-06-30","value":"3.50","vol":"6.60"},{"date":"2025-03-31","value":"4.32","vol":"7.75"},{"date":"2024-12-31","value":"4.76","vol":"6.71"},{"date":"2024-09-30","value":"4.89","vol":"7.16"},{"date":"2024-06-30","value":"4.82","vol":"6.81"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.50 | 4.32 | 4.76 | 4.89 | 4.82 |
| 行业 | 6.60 | 7.75 | 6.71 | 7.16 | 6.81 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.23","vol":"5.28"},{"date":"2025-03-31","value":"2.67","vol":"6.35"},{"date":"2024-12-31","value":"3.07","vol":"5.39"},{"date":"2024-09-30","value":"3.26","vol":"5.77"},{"date":"2024-06-30","value":"3.20","vol":"5.71"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.23 | 2.67 | 3.07 | 3.26 | 3.20 |
| 行业 | 5.28 | 6.35 | 5.39 | 5.77 | 5.71 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 27/73 ， 28/73。
[{"date":"2025-06-30","value":"18.75","vol":"26.48"},{"date":"2025-03-31","value":"16.20","vol":"26.03"},{"date":"2024-12-31","value":"15.94","vol":"25.56"},{"date":"2024-09-30","value":"16.28","vol":"24.92"},{"date":"2024-06-30","value":"16.89","vol":"24.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
18.75 | 16.20 | 15.94 | 16.28 | 16.89 |
| 行业(%) | 26.48 | 26.03 | 25.56 | 24.92 | 24.23 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.26","vol":"1.10"},{"date":"2025-03-31","value":"0.22","vol":"0.78"},{"date":"2024-12-31","value":"0.22","vol":"0.86"},{"date":"2024-09-30","value":"0.22","vol":"0.41"},{"date":"2024-06-30","value":"0.23","vol":"0.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.26 | 0.22 | 0.22 | 0.22 | 0.23 |
| 行业(%) | 1.10 | 0.78 | 0.86 | 0.41 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中泰证券 | 2025-09-28 | 买入 | 买入 |
| 天风证券 | 2025-09-24 | 买入 | |
| 华鑫证券 | 2025-09-24 | 买入 | |
| 财通证券 | 2025-09-11 | 增持 | |
| 国泰海通证券 | 2025-09-09 | 买入 | |
| 华泰金融(HK) | 2025-09-04 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"37.57","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"41.41","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"45.32","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"25.83","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"24.96","blueLineValue":"6.12","type":"YC"}]